Speechlessness in Gilles de la Tourette Syndrome: Cannabis-Based Medicines Improve Severe Vocal Blocking Tics in Two Patients
We report the cases of two young German male patients with treatment-resistant Tourette syndrome (TS), who suffer from incapacitating stuttering-like speech disfluencies caused by vocal blocking tics and palilalia. Case 1: a 19-year old patient received medical cannabis at a dose of 1 × 0.1 g cannab...
Main Authors: | Ewgeni Jakubovski, Kirsten Müller-Vahl |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2017-08-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/18/8/1739 |
Similar Items
-
Significant Tic Reduction in An Otherwise Treatment-Resistant Patient with Gilles de la Tourette Syndrome Following Treatment with Nabiximols
by: Ahmad Seif Kanaan, et al.
Published: (2017-04-01) -
Blocking Tics in Gilles de la Tourette Syndrome
by: Justyna Kaczyńska, et al.
Published: (2021-05-01) -
New insights into clinical characteristics of Gilles de la Tourette Syndrome: findings in 1032 patients from a single German center
by: Tanvi Sambrani, et al.
Published: (2016-09-01) -
The CANNA-TICS Study Protocol: A Randomized Multi-Center Double-Blind Placebo Controlled Trial to Demonstrate the Efficacy and Safety of Nabiximols in the Treatment of Adults With Chronic Tic Disorders
by: Ewgeni Jakubovski, et al.
Published: (2020-11-01) -
Pharmacological treatment of tics in Gilles de la Tourette Syndrome
by: Andrea E. Cavanna, et al.
Published: (2011-12-01)